Commensal Microbiota Promote Lung Cancer Development via γδ T Cells
Open accessAbstract
Lung cancer is closely associated with chronic inflammation, but the causes of inflammation and the specific immune mediators have not been fully elucidated. The lung is a mucosal tissue colonized by a diverse bacterial community, and pulmonary infections commonly present in lung cancer patients are linked to clinical outcomes. Here, we provide evidence that local microbiota provoke inflammation associated with lung adenocarcinoma by activating lung-resident γδ T cells. Germ-free or antibiotic-treated mice were significantly protected from lung cancer development induced by Kras mutation and p53 loss. Mechanistically, commensal bacteria stimulated Myd88-dependent IL-1β and IL-23 production from myeloid cells, inducing proliferation and activation of Vγ6+Vδ1+ γδ T cells that produced IL-17 and other effector molecules to promote inflammation and tumor cell proliferation. Our findings clearly link local microbiota-immune crosstalk to lung tumor development and thereby define key cellular and molecular mediators that may serve as effective targets in lung cancer intervention.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 31 cited sources checked · 0 supported · 0 flagged
- Findingown data
Germ-free KP mice cohoused with SPF mice have significantly greater tumor burden than germ-free-maintained counterparts.
“Ex-GF mice displayed significantly increased tumor burden compared to their counterparts maintained in the GF conditions (Figure S1A).”
Quote in the paperSubstantial claim - Findingown data
γδ T cells in tumor-bearing SPF lungs have elevated surface expression of CD44, CD69, and PD1 compared with splenic γδ T cells.
“γδ T cells in the tumor-bearing SPF lungs exhibited elevated surface expression of activation/maturity markers including CD44, CD69 and PD1 compared to those in the spleen (Figure 5C, D, E).”
Quote in the paperSubstantial claim - Findingown data
Human LUAD samples show significantly increased γδ T cell infiltration compared with normal lung tissues by immunohistochemistry.
“we also observed significantly increased infiltration of γδ T cells in human LUAD samples as compared to normal lung tissues by IHC (Figure S3B).”
Quote in the paperSubstantial claim - Findingown data
γδ T cells in tumor-bearing KP lungs exhibit a distinct gene expression signature compared with splenic γδ T cells by RNA-seq.
“Our data demonstrated that γδ T cells in the tumor-bearing KP lungs exhibited a distinct gene expression signature as compared to their splenic counterparts (Figure 7A).”
Quote in the paperSubstantial claim - Findingown data
In healthy and tumor-bearing mice, common lung bacterial genera include Staphylococcus, Streptococcus, and Lactobacillus at about 15% each and Pasteurellaceae at about 10%.
“The most common bacterial genera present in lung microbiome included Staphylococcus (~15%), Streptococcus (~15%), and Lactobacillus (~15%), along with the family Pasteurellaceae (~10%) in healthy and tumor-bearing mice.”
Quote in the paperNot a substantial claim
- Findingown data
PathSeq analysis of TCGA human lung cancer datasets identifies bacterial taxa significantly enriched or depleted in non-small cell lung cancer samples compared with normal lungs.
“PathSeq analysis of human lung cancer datasets in The Cancer Genome Atlas (TCGA) identified a number of bacterial taxa that were significantly enriched or depleted in non-small cell lung cancer samples (including squamous cell carcinoma and adenocarcinoma) as compared to normal lungs.”
Quote in the paperSubstantial claim - Findingown data
Germ-free KP mice show reduced tumor cell proliferation by Ki67 immunohistochemistry.
“At the cellular level, GF mice displayed reduced tumor cell proliferation as demonstrated by immunohistochemistry (IHC) analysis of Ki67 staining (Figure 1A).”
Quote in the paperSubstantial claim - Findingown data
The γδ T cell signature score does not correlate with the ESTIMATE immune signature score in individual patients.
“this result is not merely a reflection of the extent of immune infiltration, as indicated by the lack of correlation between the γδ T cell signature score and ESTIMATE (Yoshihara et al., 2013) immune signature score for individual patients”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Yoshihara et al., 2013 source
Not checked in the free run.
- Findingown data
Intratracheal inoculation of a bacterial consortium isolated from late-stage SPF lung tumors dramatically accelerates disease development compared with untreated controls.
“The introduction of this consortium of bacterial isolates dramatically accelerated disease development in these mice in comparison to untreated controls (Figure 2D).”
Quote in the paperSubstantial claim - Findingown data
γδ T cell abundance is dramatically increased in tumor-bearing lungs of SPF mice.
“Our data showed a dramatic increase in γδ T cell abundance associated with lung adenocarcinoma in SPF mice (Figure 3A).”
Quote in the paperSubstantial claim - Findingown data
Microbiome exposure robustly restores the γδ T17 cell compartment in ex-germ-free mice.
“we found that microbiome exposure robustly restored γδ T17 cell compartment in ex-GF mice (Figure S4E).”
Quote in the paperSubstantial claim - Findingown data
No apparent changes in proliferation of RORγt- γδ T cells or Th17 cells are observed in germ-free mice.
“By contrast, no apparent changes in the proliferation of RORγt- γδ T cells or Th17 cells were observed in GF mice (Figure S4B).”
Quote in the paperSubstantial claim - Findingown data
No substantial difference in the Th17 compartment is observed between SPF and germ-free mice.
“While no substantial difference in the Th17 compartment was observed between SPF and GF mice (Figure S3D)”
Quote in the paperSubstantial claim - Findingown data
In TCGA LUAD, patients whose expression profiles most correlate with the KP-lung γδ T cell signature (top 25%, n=128) have significantly poorer survival than low-scoring patients (bottom 25%, n=128).
“High-scoring patients (top 25%, n=128), whose gene expression profiles most correlated with the KP-lung γδ T cell signature, exhibited significantly poorer survival compared to patients with lower scores (bottom 25%, n=128) (Figure 7B).”
Quote in the paperSubstantial claim - Findingown data
Confocal immunofluorescence microscopy shows γδ T17 cell infiltration of tumor lesions in SPF lungs that is absent in germ-free lungs.
“which revealed infiltration of tumor lesions by γδ T17 cells in the SPF lungs that was absent in GF lungs (Figure 3E).”
Quote in the paperSubstantial claim - Findingown data
Hematopoietic Myd88 deficiency is associated with significantly reduced tumor growth.
“and was associated with significantly reduced tumor growth (Figure 2G).”
Quote in the paperSubstantial claim - Findingown data
The four-antibiotic cocktail does not affect tumor cell proliferation in vitro.
“Notably, antibiotic treatment did not affect the proliferation of tumor cells in vitro (Figure S1C), arguing against the possibility of direct cytotoxic effects of these antibiotics.”
Quote in the paperSubstantial claim - Findingown data
Intratracheal delivery of IL-1β and IL-23 potently induces proliferation and activation of lung γδ T17 cells.
“direct stimulation of the lung γδ T17 cells via intratracheal delivery of IL-1β and IL-23, the pro-inflammatory mediators produced by myeloid cells upon microbial exposure, potently induced their proliferation and activation (Figure 4D).”
Quote in the paperSubstantial claim - Findingown data
IL-17A protein levels in BALF and serum are significantly diminished in germ-free mice.
“IL-17A protein levels in the BALF and serum were significantly diminished in GF mice (Figure 3F).”
Quote in the paperSubstantial claim - Findingown data
Hematopoietic Myd88 deficiency inhibits IL-1β and IL-23 production from alveolar macrophages and neutrophils.
“Hematopoietic deficiency of Myd88, an essential adaptor molecule downstream of multiple toll-like receptors (TLRs), inhibited the production of IL-1β and IL-23 from alveolar macrophages and neutrophils (Figure 2F)”
Quote in the paperSubstantial claim - Findingown data
Local administration of TLR ligands LPS and PGN triggers expansion and IL-17 production of γδ T cells in the lung.
“local administration of TLR ligands (such as lipopolysaccharide, LPS and peptidoglycan, PGN) triggered the expansion and IL-17 production of γδ T cells in the lung (Figure 4C).”
Quote in the paperSubstantial claim - Findingown data
No major changes in abundance of other myeloid cell populations are observed between SPF and germ-free mice.
“we did not observe major changes in the abundance of other myeloid cell populations between SPF and GF mice (Figure S6A).”
Quote in the paperNot a substantial claim - Findingown data
Tumor-associated γδ T cell expansion is completely abrogated in germ-free mice.
“Importantly, tumor-associated γδ T cell expansion was completely abrogated in the GF mice (Figure 3A, B)”
Quote in the paperSubstantial claim - Findingown data
Lungs from tumor-bearing KP mice contain commensal bacterial communities distinct from those in the gut.
“Our data showed that the lungs from tumor-bearing KP mice harbored unique commensal bacterial communities as compared to the gut (Figure S2A).”
Quote in the paperSubstantial claim - Findingown data
Areg is robustly expressed in lung tumor-associated γδ T cells at mRNA and protein levels.
“We observed a robust expression of Areg in lung tumor-associated γδ T cells at both the mRNA and the protein levels (Figure S7B, D).”
Quote in the paperSubstantial claim - Findingown data
Patients with high IL22RA1 expression (top 30%) have significantly worse survival than the rest of the cohort.
“those with high expression (top 30%) exhibited significantly worse survival as compared to the rest of the cohort (Figure 7H).”
Quote in the paperSubstantial claim - Findingown data
Recombinant IL-22 stimulates tumor cell proliferation in vitro.
“recombinant IL-22 stimulated tumor cell proliferation in vitro (Figure S7E).”
Quote in the paperSubstantial claim - Findingown data
KP tumor-derived cell lines show dose-dependent increases in proliferation in response to recombinant Areg.
“KP tumor-derived cell lines showed dose-dependent increases in proliferation in response to recombinant Areg (Figure S7G).”
Quote in the paperSubstantial claim - Findingown data
A number of genes are highly upregulated in KP-lung associated γδ T cells compared with splenic γδ T cells, validated at mRNA and/or protein levels.
“This transcriptional signature showed a number of genes to be highly upregulated in KP-lung associated γδ T cells compared to splenic γδ T cells (Figure 7D, E), and these data were further validated at the mRNA and/or protein levels (Figure S7B, C, D).”
Quote in the paperNot a substantial claim - Findingown data
Targeting IL-22RA1 with lentivirally encoded sgRNA in KP mice harboring LSL-Cas9 leads to significant reduction in tumor burden.
“targeting IL-22RA1 led to a significant reduction in tumor burden (Figure 7F).”
Quote in the paperSubstantial claim - Interpretationown data
The correlation between the microbiome and tumor development is local.
“Of particular importance, the correlation between the microbiome and tumor development was local”
Quote in the paperSubstantial claim - Interpretationown data
Commensal microbiota promote lung cancer development via γδ T cells.
“Here we provide evidence that local microbiota provoke inflammation associated with lung adenocarcinoma by activating lung-resident γδ T cells.”
- Also stated in: § Abstract · boosted
“Our findings clearly link local microbiota-immune crosstalk to lung tumor development, and thereby define key cellular and molecular mediators that may serve as effective targets in lung cancer intervention.”
Quote in the paperSubstantial claim - Also stated in: § Abstract · boosted
- Interpretationown data
The presence of commensal bacteria maintains tissue-resident γδ T cells in homeostatic conditions.
“it indicates that the presence of commensal bacteria maintains tissue-resident γδ T cells in homeostatic conditions.”
Quote in the paperSubstantial claim - Premisecitation
IL-1β is important in γδ T cell biology as shown by the paper's data and studies in other systems.
“Given the importance of IL-1β in γδ T biology as shown by our data and studies in other systems (Sutton et al., 2009)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sutton et al., 2009 source
Not checked in the free run.
- Interpretationown data
Local microbiota provoke inflammation associated with lung adenocarcinoma by activating lung-resident γδ T cells.
“Here we provide evidence that local microbiota provoke inflammation associated with lung adenocarcinoma by activating lung-resident γδ T cells.”
Quote in the paperSubstantial claim - Interpretationown data
Tumor-associated γδ T expansion is largely due to local proliferation rather than recruitment from the circulation.
“The lung-resident origin of these γδ T cells strongly indicated that tumor-associated γδ T expansion was largely due to local proliferation rather than recruitment from the circulation.”
Quote in the paperSubstantial claim - Interpretationown data
Developing tumors in the lung hijack tissue-resident lymphocytes to establish a pro-tumorigenic microenvironment dependent on local microbiota.
“our findings describe a distinct mechanism whereby developing tumors in the lung hijack tissue-resident lymphocytes to establish a pro-tumorigenic microenvironment in a fashion dependent on the local microbiota.”
Quote in the paperSubstantial claim - Premisecitation
Increased abundance of γδ T17 cells is positively associated with tumor invasion and metastasis in LUAD patients.
“Increased abundance of γδ T17 cells was observed to be positively associated with tumor invasion and metastasis in LUAD patients, although the underlying mechanism was not defined (Bao et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bao et al., 2016 source
Not checked in the free run.
- Interpretationown data
Commensal microbiota are critical for differentiation and activation/maturation of tumor-associated γδ T cells in the lung.
“These results suggest commensal microbiota are critical for the differentiation and activation/maturation of tumor-associated γδ T cells in the lung.”
Quote in the paperSubstantial claim - Premisecitation
IL-1β inhibition with canakinumab significantly reduced lung cancer incidence and mortality in a cohort of high-risk individuals.
“a recent human clinical study reported IL-1β inhibition with the neutralizing antibody canakinumab significantly reduced lung cancer incidence and mortality in a cohort of high-risk individuals (Ridker et al., 2017).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ridker et al., 2017 source
Not checked in the free run.
- Interpretationown data
Lung cancer development in the KP model is associated with expansion and phenotypic alteration of tissue-resident γδ T cells in the tumor microenvironment.
“Taken together, our data show that lung cancer development in the KP model is associated with the expansion and phenotypic alteration of tissue-resident γδ T cells in the tumor microenvironment.”
Quote in the paperSubstantial claim - Interpretationown data
Commensal microbiota are critical for driving tumor-associated γδ T cell expansion.
“suggesting that the commensal microbiota are critical for driving this response.”
Quote in the paperSubstantial claim - Interpretationown data
IL-22 and Areg may be important mediators by which γδ T cells directly promote lung cancer cell proliferation.
“our data suggested that IL-22 and Areg may be important mediators via which γδ T cells directly promote lung cancer cell proliferation.”
Quote in the paperSubstantial claim - Interpretationown data
Microbiota-activated γδ T cells play a critical role in promoting neutrophil expansion and local inflammation through IL-17 and other pro-inflammatory factors such as CXCL2 and PTGS2.
“microbiota-activated γδ T cells did play a critical role in promoting neutrophil expansion and local inflammation through the expression of IL-17 and other pro-inflammatory factors such as CXCL2 and PTGS2.”
Quote in the paperSubstantial claim - Interpretationown data
Neutralization of IL-17 implicates an amplification loop involving myeloid cells, IL-1β, γδ T cells, and IL-17 in tumor promotion.
“implicating an amplification loop involving myeloid cells/IL-1β/γδ T cells/IL-17 in tumor promotion.”
Quote in the paperSubstantial claim
- May combine two claims. 48
- The quote only partly states this claim. 2
- Classified as probably not a substantial claim. 26
May combine two claims.
Findingown dataAmong γδ T cells in tumor-bearing SPF lungs, about 90% express RORγt and up to 75% produce IL-17A, whereas only about 5% of splenic or draining lymph node γδ T cells produce IL-17.
“Among the γδ T cells that accumulated in the tumor-bearing lungs from SPF mice, ~90% expressed the transcriptional factor RORγt and up to 75% produced the pro-inflammatory cytokine IL-17A (defining them as γδ T17 cells); by contrast, only around 5% of the total γδ T cells in the spleen or draining lymph node were IL-17 producers (Figure 3C, D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe expanded γδ T17 population in KP lungs consists primarily of Vγ6+Vδ1+ T cells, averaging 80% of total γδ T cells and more than 90% of γδ T17 cells.
“The expanded γδ T17 population in KP lungs consisted primarily of Vγ6+Vδ1+ T cells (Figure 4A). These cells accounted for an average of 80% of total γδ T cells, and more than 90% of the γδ T17 population.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataLung cancer development is associated with increased total bacterial burden and reduced bacterial diversity in bronchoalveolar lavage fluid compared with healthy non-tumor-bearing mice.
“Compared to healthy (non-tumor bearing control) mice, the development of lung cancer was associated with a significant increase in the total bacterial burden as well as reduced bacterial diversity in the airway, as measured by the total amount of 16S DNA and the Shannon index of the bacterial community in the BALF (Figure 2A, B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataGSEA shows that γδ T cells in tumor-bearing lungs resemble activated human γδ T cells, share tissue-resident αβ T cell signatures, and upregulate LPS-responsive genes.
“Gene set enrichment analysis (GSEA) further revealed that the γδ T cells in the tumor-bearing lungs exhibited a gene expression pattern similar to activated human γδ T cells (Figure 7C, a). Additionally, as tissue-resident lymphocytes, γδ T cells in KP lungs also shared common gene signatures enriched in tissue-resident αβ T cells (Figure 7C, b, c). The robust upregulation of LPS-responsive genes”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataProliferation of γδ T cells, particularly IL-17-expressing ones, is increased in tumor-bearing lungs compared with healthy lungs and is largely abrogated in germ-free mice.
“we observed increased proliferation of γδ T cells, particularly those expressing IL-17, in tumor-bearing lungs compared to healthy lungs, which was largely abrogated in the GF mice (Figure 4B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNeutrophil infiltration is increased in tumor-bearing lungs compared with healthy lungs in SPF mice and is suppressed in germ-free mice.
“neutrophil infiltration was also dramatically increased in tumor-bearing lungs compared to healthy lungs in SPF mice, and this response was suppressed in GF mice (Figure 6A).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataγδ T cells in tumor-bearing SPF lungs show minimal IFNγ or TNFα production and low Tbet expression.
“γδ T cells in the tumor-bearing lungs from SPF mice showed minimal capacity for IFNγ or TNFα production coupled with low expression of the transcription factor Tbet (Figure S5).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataγδ T cells are about 3-5% of CD3+ lymphocytes in circulation or peripheral lymphoid tissues but about 20% in tumor-bearing lung tissue of SPF mice.
“While γδ T cells only accounted for a minor fraction (~3–5%) of total CD3+ lymphocytes in the circulation (Figure 3B) or peripheral lymphoid tissues (the spleen and the draining mediastinal lymph node, Figure S3A), they were highly enriched in the tumor-bearing lung tissue of SPF mice (approximately 20% of total CD3+ lymphocytes) (Figure 3B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAnti-γδ T cell monoclonal antibodies UC7-13D5 or GL3 effectively inhibit lung γδ T cells and significantly suppress lung tumor progression.
“Both of these antibodies effectively inhibited γδ T cells in the lung (UC7–13D5: Figure S6B, C; GL3: Figure S6G, H), and significantly suppressed the progression of lung tumors (UC7–13D5: Figure 6B; GL3: Figure S6F).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIL-17A blockade decreases G-CSF expression and neutrophil infiltration in the lung and significantly reduces tumor growth and IL-1β expression.
“IL-17A blockade led to significantly decreased G-CSF expression and neutrophil infiltration in the lung, as well as a significant reduction in tumor growth and IL-1β expression (Figure 6C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataReducing commensal microbiota with the four-antibiotic cocktail decreases γδ T17 cell abundance in tumor-bearing lung and lowers IL-17A levels in BALF or serum.
“Reducing the commensal microbiota with the 4Abx cocktail dramatically decreased the abundance of γδ T17 cells in the tumor-bearing lung, resulting in lower IL-17A levels in the BALF or serum (Figure S4D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOnly a small fraction of γδ T17 cells are Vγ4+, and Vγ1+ γδ T cells make up fewer than 5% of total γδ T cells with most not expressing RORγt.
“By contrast, only a small fraction of γδ T17 cells were Vγ4+, whereas Vγ1+ γδ T cells made up fewer than 5% of total γδ T cells and most of them did not express RORγt (Figure 4A).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataγδ T cells account for more than 60% of RORγt+ or IL-17+ lymphocytes in tumor-bearing SPF lungs, with conventional CD4 Th17 cells as the other IL-17 source.
“They accounted for more than 60% of RORγt+ or IL-17+ lymphocytes whereas the other source of IL-17 was conventional CD4 T cells (i.e. Th17 cells) (Figure S3C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTreatment of SPF KP mice with a four-antibiotic cocktail at 2 or 6.5 weeks after tumor initiation suppresses tumor growth and reduces high-grade tumors.
“We found that this treatment robustly suppressed tumor growth in both early and advanced stages, resulting in significant reduction of high-grade tumors (Figure 1B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataHerbaspirillum and Sphingomonadaceae are over-represented in tumor-bearing lungs, while Aggregatibacter and Lactobacillus are enriched in healthy lungs by LEfSe.
“we identified several bacterial taxa, including Herbaspirillum and Sphingomonadaceae, that were significantly over-represented in tumor-bearing lungs, as well as a number of other taxa such as Aggregatibacter and Lactobacillus that are enriched in healthy lungs through LEfSe”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIL-1β and IL-23 p19 gene expression increases with local bacterial burden in tumor-bearing lung tissues and is abrogated in germ-free mice.
“Compared to healthy lungs, we noted a significant increase in IL-1β and IL-23 p19 gene expression associated with the increased local bacterial burden in the tumor-bearing lung tissues, and this increased cytokine expression was abrogated in GF mice (Figure 2E).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMetronidazole alone suppresses lung tumor growth without substantially reducing overall gut bacterial abundance.
“treating mice with metronidazole alone effectively suppressed tumor growth in the lung without substantially reducing the overall bacterial abundance in the gut (Figure S2C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataGerm-free mice exhibit decreased RORγt expression and IL-17 production in γδ T cells.
“GF mice also exhibited dramatically decreased RORγt expression and IL-17 production in γδ T cells (Figure 3C, D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn antibiotic-treated mice, local lung bacterial burden, but not fecal bacterial load, significantly correlates with tumor burden.
“in mice treated with antibiotics that partially eliminated the commensal bacteria, the local bacterial burden in the lung, but not the fecal bacterial load, was significantly correlated with the tumor burden (Figure 2C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataγδ T cells from tumor-bearing germ-free lungs have higher IFNγ, Tbet, and CD27 expression and lower PLZF, CD44, CD69, and PD1 expression than those from SPF lungs.
“γδ T cells from the tumor-bearing lungs of the GF mice displayed a different phenotype: they had higher expression of IFNγ, Tbet and CD27, and significantly lower expression of PLZF as well as CD44, CD69 and PD1(Figure 5A–E; Figure S5).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataInhibition of γδ T cells substantially reduces IL-17A levels, neutrophil infiltration, and tumor cell proliferation.
“Mechanistically, inhibition of γδ T cells substantially reduced IL-17A levels, neutrophil infiltration and tumor cell proliferation (Figure 6B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn germ-free KP mice, lung cancer induced by Kras mutation and p53 deletion develops more slowly than in age-matched SPF controls, with lower tumor burden, fewer tumors at 8 and 15 weeks, and fewer high-grade lesions.
“GF mice were significantly protected against lung cancer development induced by Kras mutation and p53 deletion. Compared with age-matched SPF controls, GF KP mice exhibited substantially delayed tumor growth, with diminished tumor burden and decreased tumor numbers at both 8 weeks and 15 weeks post tumor initiation, and lower percentages of high-grade lesions (Figure 1A).”
Quote in the paperSubstantial claimMay combine two claims. The quote only partly states this claim.
Findingown dataγδ T cells in tumor-bearing lungs are largely PLZF positive and have low surface CD27 compared with splenic γδ T cells.
“In contrast to splenic γδ T cells, γδ T cells in the tumor-bearing lungs were largely positive for PLZF (promyelocytic leukemia zinc finger) (Figure 5A)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIL-17 production from γδ T cells in tumor-bearing lungs is substantially enhanced compared with healthy lungs and is associated with increased airway bacterial load.
“associated with the increased bacterial load in the airway, IL-17 production from γδ T cells in the tumor-bearing lungs was substantially enhanced as compared to that from cells in healthy lungs (Figure S4C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataγδ T cells in KP lungs strongly express IL-17A, IL-17F, CXCL2, PTGS2, IL-1R1, and IL-23R.
“In addition to IL-17A and IL-17F, γδ T cells in the KP lungs strongly expressed other effector molecules that might contribute to tumor-promoting inflammation. For example, CXCL2 is a neutrophil chemoattractant, whereas PTGS2 (prostaglandin-endoperoxide synthase 2) is essential for the biosynthesis of prostaglandin, a potent inflammatory mediator. IL-1R1 and IL-23R expression were also elevated in”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIL-22 is among top differentially expressed genes and is up-regulated in lung-tumor associated γδ T cells.
“Among the top differentially expressed genes, IL-22 is an epithelial growth factor significantly up-regulated in lung-tumor associated γδ T cells.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe bacterial strains isolated from late-stage SPF KP lung tumors included Aneurinibacillus aneurinilyticus, Lactobacillus murinus, Lactobacillus reuteri, Streptococcus acidominimus, Corynebacterium, Propionibacterium acnes, Brevibacterium massiliense, Microbacterium lacticum, Lactococcus, Bifidobacterium (potentially pseudolongum), Acinetobacter radioresistens, and three Staphylococcus strains.
“All organisms were identified using universal 16s rRNA gene primers and sanger sequencing, including Aneurinibacillus aneurinilyticus, Lactobacillus murinus, Lactobacillus reuteri, Streptococcus acidominimus, Corynebacterium, Propionibacterium acnes, Brevibacterium massiliense, Microbacterium lacticum, Lactococcus, Bifidobacterium (potentially pseudolongum), Acinetobacter radioresistens and 3 stra”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. The quote only partly states this claim.
Findingnone givenFourteen bacterial strains were isolated and cultured from late-stage lung tumors of SPF KP mice.
“14 bacterial strains were isolated and cultured from late-stage lung tumors from SPF mice.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataDysregulation of local microbiota stimulates tissue-resident γδ T cells, which produce IL-17 and other pro-inflammatory mediators to promote neutrophil expansion and tumor cell proliferation.
“Our data support a model in which this dysregulation of local microbiota stimulates tissue-resident γδ T cells, which in turn produce IL-17 and other pro-inflammatory mediators to promote neutrophil expansion and tumor cell proliferation.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOverall survival rates for human LUAD remain very low despite targeted therapies for some genetic subtypes.
“Despite the recent development of targeted therapies for some genetic subtypes of human LUAD, overall survival rates for this cancer remain very low (Herbst et al., 2018).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Herbst et al., 2018 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitationγδ T cells can have protective or tumor-promoting functions in cancer, and tumor-promoting activities have been ascribed to distinct mechanisms in different cancers.
“γδ T cells can have either protective roles or tumor-promoting functions in cancer; tumor-promoting activities of γδ T cells have been ascribed to distinct mechanisms in different types of cancers (Daley et al., 2016; Silva-Santos et al., 2015).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe course of lung cancer is frequently complicated by pulmonary infections.
“The course of lung cancer is frequently complicated by pulmonary infections (Akinosoglou et al., 2013)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Akinosoglou et al., 2013
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenMice were randomized before treatments.
“Mice were randomized before treatments.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIncreased Areg levels correlate with poor prognostic outcome and poor response to therapy in lung cancer patients.
“Increased Areg levels have been correlated with a poor prognostic outcome and poor response to therapy in lung cancer patients (Busser et al., 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Busser et al., 2011
Not checked in the free run.
May combine two claims.
Interpretationown dataCommensal bacteria stimulate Myd88-dependent IL-1β and IL-23 production from myeloid cells, inducing proliferation and activation of Vγ6+Vδ1+ γδ T cells that produce IL-17 and other effector molecules to promote inflammation and tumor cell proliferation.
“Mechanistically, commensal bacteria stimulated Myd88-dependent IL-1β and IL-23 production from myeloid cells, inducing proliferation and activation of Vγ6+Vδ1+ γδ T cells that produced IL-17 and other effector molecules to promote inflammation and tumor cell proliferation.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataLung tumor burden is highly correlated with local bacterial abundance in the airway, but not the intestinal tract, indicating a relatively more significant contribution of local microbiota in lung cancer development.
“Our data showed that lung tumor burden was highly correlated with local bacterial abundance in the airway, but not the intestinal tract, indicating a relatively more significant contribution of the local microbiota in lung cancer development.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationIL-17A has been implicated both in tumor-promoting inflammation and anti-tumor immunity, with contradictory roles in different lung cancer models.
“IL-17A has been implicated both in tumor-promoting inflammation and anti-tumor immunity, with contradictory roles being reported for IL-17A in different models of lung cancer (Chang et al., 2014; Cheng et al., 2014).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
Interpretationown dataMicrobiota-activated γδ T cells may promote lung cancer progression by directly stimulating tumor cell proliferation via IL-22 and Areg, in addition to stimulating inflammation.
“These findings, together with the data on the IL-22 pathway, provide strong evidence that microbiota-activated γδ T cells may promote lung cancer progression by directly stimulating tumor cell proliferation, in addition to stimulating inflammation in the lung microenvironment.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningBoth the microbiome and genes responsible for tumor initiation are key to the observed changes in γδ T cell numbers.
“In this case, both the microbiome and genes responsible for tumor initiation are key to the observed changes in γδ T cell numbers.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationVγ6+ γδ T cells are long-lived tissue-resident cells that colonize the lung during embryonic development and self-renew under homeostatic conditions.
“Vγ6+ γδ T cells are long-lived, tissue-resident cells that colonize the lung during embryonic development and undergo self-renewal under homeostatic conditions (Haas et al., 2012).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Haas et al., 2012 source
Not checked in the free run.
May combine two claims.
Interpretationown dataMicrobiota-induced γδ T cells promote neutrophil infiltration and tumor development.
“Microbiota-induced γδ T cells promote neutrophil infiltration and tumor development.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIL-22 is known to exert a tumor-promoting effect in colorectal cancer.
“Although known to exert a tumor-promoting effect in colorectal cancer (Kirchberger et al., 2013; Wang et al., 2017)”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
Interpretationown dataCommensal microbiota not only impact γδ T cell abundance but also determine their functionality.
“These results imply that commensal microbiota not only impact the abundance of γδ T cells, but also play a critical role in determining their functionality.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCommensal microbiota can affect outcomes of immunotherapeutic interventions in human cancers.
“Recent data have shown that commensal microbiota can affect the outcomes of immunotherapeutic interventions in human cancers (Gopalakrishnan et al., 2018; Routy et al., 2018).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
InterpretationreasoningThis process may further potentiate inflammation and dysbiosis, establishing a vicious cycle that exacerbates tumor growth.
“This may further potentiate inflammation and dysbiosis, establishing a vicious cycle that exacerbates tumor growth.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationNeutrophils promote tumorigenesis and cancer metastasis in various tumor models including lung cancer.
“While neutrophils are known to promote tumorigenesis and cancer metastasis in various tumor models including lung cancer (Coffelt et al., 2016)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Coffelt et al., 2016 source
Not checked in the free run.
May combine two claims.
Interpretationown dataLung tumor growth in the KP model is associated with increased total bacterial load and reduced bacterial diversity, suggesting tumor-associated barrier defects and airway obstruction might impair bacterial clearance and alter microbial growth conditions.
“Our findings demonstrate that lung tumor growth in the KP model is associated with increased total bacterial load and reduced bacterial diversity in the airway, suggesting that tumor-associated barrier defects and airway obstruction might result in impaired bacterial clearance and altered growth conditions for microbes.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationLung cancer development is closely associated with chronic inflammation characterized by inflammatory cell infiltration and pro-inflammatory factors that stimulate proliferation, angiogenesis, remodeling, or metastasis.
“The development of lung cancer is closely associated with chronic inflammation characterized by infiltration of inflammatory cells and accumulation of pro-inflammatory factors including cytokines, chemokines and prostaglandins that stimulate cell proliferation, angiogenesis, tissue remodeling or metastasis (Palucka and Coussens, 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Palucka and Coussens, 2016
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe genomic landscape of LUAD has been extensively characterized.
“Although the genomic landscape of LUAD has been extensively characterized (Campbell et al., 2016; Cancer Genome Atlas Research, 2014)”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Campbell et al., 2016 source
Not checked in the free run.
- cites Cancer Genome Atlas Research, 2014
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIntestinal microbiota can promote local inflammation and gastrointestinal cancers but can also exert an opposing effect on transplanted tumors at distal sites by priming systemic anti-tumor immunity.
“while the intestinal microbiota can promote local inflammation and development of gastrointestinal cancers (Elinav et al., 2013; Garrett, 2015), it can exert an opposing effect on transplanted tumors at distal sites by priming the host immune system and enhancing the systemic anti-tumor immune response (Dzutsev et al., 2017).”
Quote in the paperNot a substantial claim0 of 3 sources checkedClassified as probably not a substantial claim.
PremisecitationPLZF is essential for development of tissue-resident IL17-producing Vγ6+ γδ T cells.
“which is a transcription factor essential for the development of tissue-resident IL17-producing Vγ6+ γδ T cells (Lu et al., 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lu et al., 2015
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationBacterial infections occur in up to 70% of lung cancer patients and markedly influence clinical outcome and patient survival.
“Bacterial infections occur in up to 70% lung cancer patients and markedly influence the clinical outcome and patent survival (Hsu-Kim et al., 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hsu-Kim et al., 2013 source
Not checked in the free run.
May combine two claims.
Interpretationown dataIntratracheal inoculation of bacteria isolated from late-stage lung tumors and local administration of LPS/PGN strongly suggest the importance of lung microbiota in driving local inflammation and tumor promotion.
“In addition, we demonstrated that intratracheal inoculation of a consortium of bacteria isolated from late-stage lung tumors significantly accelerated tumor growth, and that local administration of bacterial products (LPS and PGN) robustly stimulated γδ T cells in the lung. These results strongly suggest the importance of lung microbiota in driving local inflammation and tumor promotion.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenBoth male and female mice were used in all experimental groups in all mouse experiments.
“Both male and female mice were used in all experimental groups in all mouse experiments.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataEarly tumor development upon Kras activation and p53 loss acts via local microbiota to amplify the γδ T cell response by stimulating proliferation, which promotes tumor progression.
“Our data support a model in which early tumor development upon Kras activation and p53 loss acts via the local microbiota to amplify the γδ T cell response by stimulating their proliferation, which in turn promotes tumor progression.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataγδ T cells are the predominant IL-17 producing cells that accumulate in the lung in response to tumor development in a microbiota-dependent manner.
“Collectively, these data demonstrate that γδ T cells are the predominant IL-17 producing cells that accumulate in the lung in response to tumor development in a microbiota-dependent manner.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationChanges in the local microbial community are associated with exacerbation of chronic obstructive pulmonary disease, asthma, and cystic fibrosis.
“Changes in this local microbial community have been associated with the exacerbation of several pulmonary disorders, including chronic obstructive pulmonary disease, asthma and cystic fibrosis (Dickson et al., 2016; Marsland and Gollwitzer, 2014).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Dickson et al., 2016 source
Not checked in the free run.
- cites Marsland and Gollwitzer, 2014
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCulture-independent sequencing studies have identified microbial communities with complex bacterial diversity in the lower respiratory tract.
“recent culture-independent sequencing studies have identified the presence of microbial communities containing a complex diversity of bacteria in the lower respiratory tract (Dickson et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Dickson et al., 2016 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPost-obstructive pneumonia can negatively affect the efficacy of lung cancer therapy and overall survival of cancer patients.
“post-obstructive pneumonia can negatively affect the efficacy of lung cancer therapy and overall survival of cancer patients (Qiao et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Qiao et al., 2015
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationCD27 is critical for differentiation of IFNγ-producing γδ T cells.
“which is critical for the differentiation of IFNγ-producing γδ T cells (Ribot et al., 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ribot et al., 2009 source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductown dataGerm-free status was verified by microbiological culture and fecal PCR every two weeks.
“The germ-free status was confirmed by microbiological monitoring by culture and fecal PCR, alternatively every two weeks.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductown dataThe germ-free KP mice used in the study were produced by embryo transfer under sterile conditions.
“The germ-free KP mice used in this study were derived by embryo transfer using sterile techniques.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataFecal DNA from germ-free mice produced no 16S qPCR signal after 40 cycles, while SPF mouse fecal DNA had Ct values of 6-8 cycles.
“Fecal DNA of GF mice didn’t give any signal in 40 cycles, whereas those from SPF mice had Ct values of 6–8 cycles.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataAt least five mice per group were included in the tumor burden and immunohistochemistry analyses.
“at least five mice per groups were included in the analyses.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenTumor burden grading and immunohistochemistry analyses were performed with blinding.
“All tumor burden/grading and IHC analyses were done in a blinded fashion”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe mice were inspected for typical germ-free features such as an enlarged cecum when tissues were collected.
“we also inspected the mice for the typical appearance of GF animals such as the enlarged cecum at the time of tissue collection.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductcitationThe intravascular staining method labeled circulating hematopoietic cells but not those located inside the tissue.
“This procedure labeled all hematopoietic cells in the circulation but not those localized inside the tissue (Anderson et al., 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Anderson et al., 2014 source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductnone givenThe re-derived KP mice were kept germ-free by following strict standard operating procedures to prevent contamination.
“The re-derived KP mice were maintained in germ-free conditions by following stringent standard operating procedures to prevent contamination.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataTLR ligands from lung microbiota may stimulate IL-1β and IL-23 production from alveolar macrophages and neutrophils in a Myd88-dependent manner, inducing proliferation and activation of lung-resident γδ T cells to augment the inflammatory response.
“Mechanistically, TLR ligands derived from the lung microbiota may stimulate the production of IL-1β and IL-23 from alveolar macrophages and neutrophils in a Myd88-dependent manner, and thereby induce proliferation and activation of lung-resident γδ T cells to further augment the inflammatory response.”
Quote in the paperSubstantial claim
The paper relies on this without support.
The KP mouse model faithfully reproduces the genetic and histopathological features of human LUAD.
“This autochthonous model of LUAD not only faithfully mimics the genetic and histopathological features of the human disease”
The paper relies on this without support.
Commensal bacteria are otherwise non-pathogenic and colonize pulmonary tissue at much lower density in healthy individuals.
“which are otherwise non-pathogenic and colonize pulmonary tissue at a much lower density in healthy individuals”
The paper relies on this without support.
IL-22RA1 determines cellular sensitivity towards IL-22.
“As IL-22RA1 determines cellular sensitivity towards IL-22”
The paper relies on this without support.
The tumor-cell extrinsic factors that control lung cancer development are less well understood.
“the tumor-cell extrinsic factors that control lung cancer development are less well understood.”
The paper relies on this without support.
The mechanisms responsible for tumor-associated inflammation in lung cancer have not been clearly defined.
“However, the underlying mechanisms responsible for the tumor-associated inflammation in lung cancer have not been clearly defined.”
The paper relies on this without support.
It remains to be elucidated how developing tumor lesions exploit the lung-resident immune system and how non-host factors influence this process.
“In particular, it remains to be elucidated how the developing tumor lesions exploit the lung-resident immune system to create the tumor-promoting microenvironment, and how this process is influenced by non-host derived factors.”
The paper relies on this without support.
The role of distal gut or local lung microbiota in lung cancer has not been elucidated.
“Despite accumulating evidence linking microbiota to cancer, the role of distal (gut) or local (lung) microbiota in lung cancer has not been elucidated.”
The paper relies on this without support.
The associations between lung microbiota and cancer are not understood mechanistically.
“However, these associations are not understood mechanistically.”
The paper relies on this without support.
The upstream signal inducing neutrophil expansion in KP tumors has not been clearly identified.
“the upstream signal inducing the expansion of neutrophils in the KP tumors has not been clearly identified.”
The paper relies on this without support.
The role of IL-22 in lung cancer has not been well studied.
“the role of IL-22 in lung cancer has not been well studied.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Increasing evidence supports an additional category of complicit microbes and microbial functions that promote carcinogenesis but are not sufficient to cause cancer.
“Increasing evidence suggests an important additional category of “complicit” microbes and microbial functions that promote carcinogenesis but are insufficient to cause cancer (18, 20, 25, 38, 44–47).”
From The microbiome and human cancer (2021) · cites this paper as [18]
Evidence suggests that intratumoral bacteria exist and are functionally active, with overlapping immunohistochemistry, immunofluorescence, electron microscopy, and sequencing data across about 10 cancer types.
“Emerging evidence also suggests the existence and functional activity of intratumoral bacteria, with overlapping immunohistochemistry, immunofluorescence, electron microscopy, and sequencing data on them in ~10 cancer types.”
From The microbiome and human cancer (2021) · cites this paper as [18]
Kras mutation and p53 loss do not produce lung cancer in germ-free or antibiotic-treated mice; commensal lung microbiota promote expansion and activation of γδ T cells, driving tumor-promoting inflammation via local IL-17 and IL-23 release.
“A third comes from the inability of Kras mutation and p53 loss to produce lung cancer in germ-free or antibiotic-treated mice: commensal lung microbiota promote expansion and activation of γδ T cells, which drives tumor-promoting inflammation via local IL-17 and IL-23 release (18).”
From The microbiome and human cancer (2021) · cites this paper as [18]
Intratumor microbes often create tolerogenic programming through PRR ligation, with lower proportions of tumor-infiltrating lymphocytes including CD8+ T cells, and occasionally more CD4+CD25+FoxP3+ Tregs, as observed in colorectal, pancreatic, breast, and lung cancers.
“Immunologically, intratumor microbes often create tolerogenic programming through PRR ligation with lower proportions of TILs, including CD8+ T cells, and occasionally more CD4+CD25+FoxP3+ Tregs, as observed in colorectal, pancreatic, breast, and lung cancers (18, 23, 34, 46, 75, 101, 102).”
From The microbiome and human cancer (2021) · cites this paper as [18]
Intratumor microbes have cancer-specific effects on CagA-mediated or IL-17-producing γδ T cell-mediated inflammation in stomach and lung cancers.
“(ii) CagA-mediated or IL-17-producing γδ T cell-mediated inflammation in stomach and lung cancers, respectively (18, 103)”
From The microbiome and human cancer (2021) · cites this paper as [18]
Extra-intestinal cancers can develop within tissues that harbor their own microbiome, and that microbiome may play a role in exacerbating neoplasia.
“However, it is noteworthy that extra-intestinal cancers can develop within tissues that harbor their own microbiome and may play a role in the exacerbation of neoplasia (12, 18, 25, 46).”
From The microbiome and human cancer (2021) · cites this paper as [18]
In oncogene-driven autochthonous lung cancer models in mice, local commensals may be perturbed by carcinogenesis, triggering inflammatory cross-talk between alveolar macrophages and IL-17-producing lung resident γδ T cells that contributes to tumor progression.
“Experimental evidence in oncogene-driven autochthonous lung cancer models in mice unveiled that local commensals may be perturbed by carcinogenesis, triggering an inflammatory cross-talk between alveolar macrophages and IL-17 producing lung resident γδ T cells contributing to tumor progression (18).”
From The microbiome and human cancer (2021) · cites this paper as [18]
Cultivable bacteria have been demonstrated by other studies in breast, lung, prostate, pancreatic, and colon cancers.
“However, other studies have indeed shown cultivable bacteria in breast (127–129), lung (18), prostate (130, 131), pancreas (14, 15), and colon cancers (19, 132)”
From The microbiome and human cancer (2021) · cites this paper as [18]
Research in lung, colon, and pancreatic cancer indicates that removing intratumoral microbiota can halt tumor-promoting inflammation, lower cellular proliferation, or shift a tolerogenic tumor microenvironment toward an immunogenic one.
“Several studies in lung, colon, and pancreatic cancer suggest that eliminating intratumoral microbiota can check tumor-promoting inflammatory processes, reduce cellular proliferation, or convert a tolerogenic TME to an immunogenic one (18, 19, 23, 46).”
From The microbiome and human cancer (2021) · cites this paper as [18]
Kras mutation and loss of p53 failed to promote lung tumorigenesis in antibiotic-treated/germ-free mice because lung microbiota can promote tumorigenesis via IL-23 and IL-17 production, leading to tumor-promoting inflammation.
“Moreover, Kras mutation and loss of p53 failed to promote lung tumorigenesis in antibiotic‐treated/germ‐free mice because lung microbiota could promote tumorigenesis via IL‐23 and IL‐17 production, leading to tumor‐promoting inflammation [409].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [409]
Microbes promote cytotoxin-associated gene A- or T cell-mediated inflammation in stomach and lung cancers, respectively.
“promote cytotoxin‐associated gene A‐ or T cell‐mediated inflammation as shown in stomach and lung cancers, respectively [409, 414]”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [409]
Cites
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302 · see citing works
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607 · see citing works
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887 · see citing works
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179 · see citing works
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192 · see citing works
Inferring tumour purity and stromal and immune cell admixture from expression data
Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778 · see citing works
Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Lozupone, C., Turnbaugh, P. J., Fierer, N., & Knight, R. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000080107 · Cited by 9,633 · see citing works
Independent component analysis: algorithms and applications
Hyvärinen, A., & Erkki Oja, A. (2000) · Neural Networks · doi:10.1016/s0893-6080(00)00026-5 · Cited by 8,726 · see citing works
Comprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732 · see citing works
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671 · see citing works
The biology and management of non-small cell lung cancer
Herbst, R. S., Morgensztern, D., & Boshoff, C. (2018) · Nature · doi:10.1038/nature25183 · Cited by 4,891 · see citing works
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812 · see citing works
Full-length RNA-seq from single cells using Smart-seq2
Picelli, S., Faridani, O. R., Björklund, Å. K., Winberg, G., Sagasser, S., & Sandberg, R. (2014) · Nature Protocols · doi:10.1038/nprot.2014.006 · Cited by 4,137 · see citing works
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
Barbie, D. A., Tamayo, P., Boehm, J. S., Kim, S. Y., Moody, S. E., Dunn, I. F., Schinzel, A. C., Sandy, P., Meylan, E., Scholl, C., et al. (2009) · Nature · doi:10.1038/nature08460 · Cited by 3,869 · see citing works
Self-citationKostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718 · see citing works
Self-citationInflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms
Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3611 · Cited by 2,000 · see citing works
Self-citationAnalysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasPreprint
Jackson, E. L., Willis, N. A., Mercer, K. L., Bronson, R. T., Crowley, D. G., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,877 · see citing works
Self-citationNeutrophils in cancer: Neutral no more
Coffelt, S. B., Wellenstein, M. D., & de Visser, K. E. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.52 · Cited by 1,830 · see citing works
Bullard, J. H., Purdom, E., Hansen, K. D., & Dudoit, S. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-94 · Cited by 1,680 · see citing works
Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer
Bullman, S., Pedamallu, C. S., Sicinska, E., Clancy, T. E., Zhang, X., Cai, D., Neuberg, D., Huang, K., Guevara, F., Nelson, T., et al. (2017) · Science · doi:10.1126/science.aal5240 · Cited by 1,574 · see citing works
Self-citationSutton, C. E., Lalor, S. J., Sweeney, C. M., Brereton, C. F., Lavelle, E. C., & Mills, K. H. G. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.001 · Cited by 1,553 · see citing works
Garrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404 · see citing works
Ridker, P. M., MacFadyen, J. G., Thuren, T., Everett, B. M., Libby, P., Glynn, R. J., Ridker, P., Lorenzatti, A., Krum, H., Varigos, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32247-x · Cited by 1,344 · see citing works
Adenoma–linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Grivennikov, S. I., Wang, K., Mucida, D., Stewart, C. A., Schnabl, B., Jauch, D., Taniguchi, K., Yu, G.-Y., Österreicher, C. H., Hung, K. E., et al. (2012) · Nature · doi:10.1038/nature11465 · Cited by 1,327 · see citing works
EBSeq: an empirical Bayes hierarchical model for inference in RNA-seq experiments
Leng, N., Dawson, J. A., Thomson, J. A., Ruotti, V., Rissman, A. I., Smits, B. M. G., Haag, J. D., Gould, M. N., Stewart, R. M., & Kendziorski, C. M. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt087 · Cited by 1,304 · see citing works
Immunoglobulin A Coating Identifies Colitogenic Bacteria in Inflammatory Bowel Disease
Palm, N. W., de Zoete, M. R., Cullen, T. W., Barry, N. A., Stefanowski, J., Hao, L., Degnan, P. H., Hu, J., Peter, I., Zhang, W., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.006 · Cited by 1,286 · see citing works
Six-of-the-best: unique contributions of γδ T cells to immunology
Vantourout, P., & Hayday, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3384 · Cited by 1,232 · see citing works
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
Cancer Genome Atlas Research Network, Campbell, J. D., Alexandrov, A., Kim, J., Wala, J., Berger, A. H., Pedamallu, C. S., Shukla, S. A., Guo, G., Brooks, A. N., et al. (2016) · Nature Genetics · doi:10.1038/ng.3564 · Cited by 1,200 · see citing works
Self-citationThe Microbiome and the Respiratory Tract
Dickson, R. P., Erb-Downward, J. R., Martinez, F. J., & Huffnagle, G. B. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105238 · Cited by 953 · see citing works
Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase
DuPage, M. J. P., Dooley, A. L., & Jacks, T. (2009) · Nature Protocols · doi:10.1038/nprot.2009.95 · Cited by 862 · see citing works
Self-citationPalucka, A. K., & Coussens, L. M. (2016) · Cell · doi:10.1016/j.cell.2016.01.049 · Cited by 843 · see citing works
Intravascular staining for discrimination of vascular and tissue leukocytes
Anderson, K. G., Mayer-Barber, K., Sung, H., Beura, L., James, B. R., Taylor, J. J., Qunaj, L., Griffith, T. S., Vezys, V., Barber, D. L., et al. (2014) · Nature Protocols · doi:10.1038/nprot.2014.005 · Cited by 812 · see citing works
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
Romero, R., Sayin, V. I., Davidson, S. M., Bauer, M. R., Singh, S. X., LeBoeuf, S. E., Karakousi, T. R., Ellis, D. C., Bhutkar, A., Sánchez-Rivera, F. J., et al. (2017) · Nature Medicine · doi:10.1038/nm.4407 · Cited by 652 · see citing works
Self-citationRibot, J. C., deBarros, A., Pang, D. J., Neves, J. F., Peperzak, V., Roberts, S. J., Girardi, M., Borst, J., Hayday, A. C., Pennington, D. J., et al. (2009) · Nature Immunology · doi:10.1038/ni.1717 · Cited by 628 · see citing works
Silva-Santos, B., Serre, K., & Norell, H. (2015) · Nature reviews. Immunology · doi:10.1038/nri3904 · Cited by 565 · see citing works
Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model
Kirchberger, S., Royston, D. J., Boulard, O., Thornton, E., Franchini, F., Szabady, R. L., Harrison, O., & Powrie, F. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122308 · Cited by 529 · see citing works
A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells
Singer, M., Wang, C., Cong, L., Marjanovic, N. D., Kowalczyk, M. S., Zhang, H., Nyman, J., Sakuishi, K., Kurtuluş, S., Gennert, D. G., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.052 · Cited by 414 · see citing works
Host–microorganism interactions in lung diseases
Marsland, B. J., & Gollwitzer, E. S. (2014) · Nature reviews. Immunology · doi:10.1038/nri3769 · Cited by 351 · see citing works
Development of interleukin-17-producing γδ T cells is restricted to a functional embryonic wave
Haas, J. D., Ravens, S., Düber, S., Sandrock, I., Oberdörfer, L., Kashani, E., Chennupati, V., Föhse, L., Naumann, R., Weiss, S., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.06.003 · Cited by 348 · see citing works
A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma
Tammela, T., Rivera, F. J. S., Cetinbas, N. M., Wu, K., Joshi, N. S., Helenius, K. P., Park, Y., Azimi, R., Kerper, N. R., Wesselhoeft, R. A., et al. (2017) · Nature · doi:10.1038/nature22334 · Cited by 338 · see citing works
Self-citationγδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation
Daley, D., Zambirinis, C. P., Seifert, L., Akkad, N., Mohan, N., Werba, G., Barilla, R., Torres-Hernandez, A., Hundeyin, M., Mani, V. R. K., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.046 · Cited by 329 · see citing works
T helper 17 cells play a critical pathogenic role in lung cancer
Chang, S. H., Mirabolfathinejad, S. G., Katta, H., Cumpian, A. M., Gong, L., Caetano, M. S., Moghaddam, S. J., & Dong, C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319051111 · Cited by 326 · see citing works
PathSeq: software to identify or discover microbes by deep sequencing of human tissue
Kostic, A. D., Ojesina, A. I., Pedamallu, C. S., Jung, J., Verhaak, R. G. W., Getz, G. A., & Meyerson, M. M. (2011) · Nature Biotechnology · doi:10.1038/nbt.1868 · Cited by 317 · see citing works
Self-citationIL-17+ γδ T cells as kick-starters of inflammation
Papotto, P. H., Ribot, J. C., & Silva‐Santos, B. (2017) · Nature Immunology · doi:10.1038/ni.3726 · Cited by 305 · see citing works
Dzutsev, A., Badger, J. H., Perez-Chanona, E., Roy, S., Salcedo, R., Smith, C. K., & Trinchieri, G. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052133 · Cited by 302 · see citing works
Multiple cells-of-origin of mutant K-Ras–induced mouse lung adenocarcinoma
Sutherland, K. D., Song, J., Kwon, M. C., Proost, N., Zevenhoven, J., & Berns, A. J. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319963111 · Cited by 267 · see citing works
Lung Homeostasis: Influence of Age, Microbes, and the Immune System
Lloyd, C. M., & Marsland, B. J. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.005 · Cited by 254 · see citing works
The multiple roles of amphiregulin in human cancer
Busser, B., Sancey, L., Brambilla, E. M., Coll, J., & Hurbin, A. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.05.003 · Cited by 251 · see citing works
Biton, A., Bernard‐Pierrot, I., Lou, Y., Krucker, C., Chapeaublanc, E., Rubio-Pérez, C., López-Bigas, N., Kamoun, A., Neuzillet, Y., Gestraud, P., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.035 · Cited by 213 · see citing works
Cheng, M., Qian, L., Shen, G., Bian, G., Xu, T., Xu, W., Shen, G., & Hu, S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2462 · Cited by 182 · see citing works
Yun, Y., Srinivas, G., Kuenzel, S., Linnenbrink, M., Alnahas, S., Bruce, K. D., Steinhoff, U., Baines, J. F., & Schaible, U. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113466 · Cited by 168 · see citing works
Subset-specific, uniform activation among Vγ6/Vδ1+ γδ T cells elicited by inflammation
Roark, C. L., Aydintug, M. K., Lewis, J., Yin, X., Lahn, M., Hahn, Y., Born, W. K., Tigelaar, R. E., & O’Brien, R. L. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0703326 · Cited by 88 · see citing works
Infectious complications in patients with lung cancer.
Akinosoglou, K., Karkoulias, K., & Marangos, M. N. (2013) · PubMed · Cited by 84 · see citing works
INFECTIOUS COMPLICATIONS IN PATIENTS WITH LUNG CANCER
Grigorievskaya, Z. V. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.17650/1818-8338-2011-1-9-13 · Cited by 81 · see citing works
PLZF controls the development of fetal-derived IL-17+Vγ6+ γδT-cells
Lu, Y., Cao, X., Zhang, X., & Kovalovsky, D. (2015) · Journal of Immunology · doi:10.4049/jimmunol.1500939 · Cited by 69 · see citing works
A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells
Singer, M., Wang, C., Cong, L., et al. (2017) · Cell · doi:10.1016/j.cell.2017.11.006 · Cited by 69 · see citing works
Wang, C., Gong, G., Sheh, A., Muthupalani, S., Bryant, E. M., Puglisi, D. A., Holcombe, H., Conaway, E. A., Parry, N. A. P., Bakthavatchalu, V., et al. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.9 · Cited by 66 · see citing works
Self-citationAntibodies and methods for immunohistochemistry of extracellular matrix proteins
Rickelt, S., & Hynes, R. O. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.04.011 · Cited by 51 · see citing works
Development of a Stable Lung Microbiome in Healthy Neonatal Mice
Kostrić, M., Milger, K., Krauss‐Etschmann, S., Engel, M., Vestergaard, G., Schloter, M., & Schöler, A. (2017) · Microbial Ecology · doi:10.1007/s00248-017-1068-x · Cited by 42 · see citing works
IL-17A-producing T cells are associated with the progression of lung adenocarcinoma
Bao, Z., Lu, G., Cui, D., Yao, Y., Yang, G., & Zhou, J. (2016) · Oncology Reports · doi:10.3892/or.2016.4837 · Cited by 30 · see citing works
The microbiology of postobstructive pneumonia in lung cancer patients
Hsu-Kim, C., Hoag, J. B., Cheng, G.-S., & Lund, M. E. (2013) · Journal of Bronchology & Interventional Pulmonology · doi:10.1097/lbr.0b013e31829ddf01 · Cited by 27 · see citing works
Qiao, D., Wang, Z., Lu, Y., et al. (2015) · PubMed · Cited by 24 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Hallmarks of Cancer: New Dimensions
Hanahan, D. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1059 · Cited by 9,887 · see citing works
Interaction between microbiota and immunity in health and disease
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Research · doi:10.1038/s41422-020-0332-7 · Cited by 3,947 · see citing works
Inflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806 · see citing works
The microbiome and human cancer
Sepich-Poore, G. D., Zitvogel, L., Straussman, R., Hasty, J., Wargo, J. A., & Knight, R. (2021) · Science · doi:10.1126/science.abc4552 · Cited by 1,332 · see citing works
RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancer diagnostic approach
Poore, G. D., Kopylova, E., Zhu, Q., Carpenter, C., Fraraccio, S., Wandro, S., Kosciolek, T., Janssen, S., Metcalf, J., Song, S. J., et al. (2020) · Nature · doi:10.1038/s41586-020-2095-1 · Cited by 989 · see citing works
RetractedTumor-resident intracellular microbiota promotes metastatic colonization in breast cancer
Fu, A., Yao, B., Dong, T., Chen, Y., Yao, J., Liu, Y., Li, H., Bai, H., Liu, X., Zhang, Y., et al. (2022) · Cell · doi:10.1016/j.cell.2022.02.027 · Cited by 981 · see citing works
Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer
Galeano Niño, J. L., Wu, H., LaCourse, K. D., Kempchinsky, A. G., Baryiames, A., Barber, B., Futran, N., Houlton, J., Sather, C., Sicinska, E., et al. (2022) · Nature · doi:10.1038/s41586-022-05435-0 · Cited by 887 · see citing works
Self-citationMechanisms and Implications of Metabolic Heterogeneity in Cancer
Kim, J., & DeBerardinis, R. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.013 · Cited by 606 · see citing works
MAIT cells are imprinted by the microbiota in early life and promote tissue repair
Constantinides, M. G., Link, V. M., Tamoutounour, S., Wong, A. C., Perez-Chaparro, P. J., Han, S.-J., Chen, Y. E., Li, K., Farhat, S., Weckel, A., et al. (2019) · Science · doi:10.1126/science.aax6624 · Cited by 567 · see citing works
Identification of bacteria-derived HLA-bound peptides in melanoma
Kalaora, S., Nagler, A., Nejman, D., Alon, M., Barbolin, C., Barnea, E., Ketelaars, S. L. C., Cheng, K., Vervier, K., Shental, N., et al. (2021) · Nature · doi:10.1038/s41586-021-03368-8 · Cited by 457 · see citing works
Wang, H., Rong, X., Zhao, G., Zhou, Y., Xiao, Y., Ma, D., Jin, X., Wu, Y., Yan, Y., Yang, H., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.02.010 · Cited by 411 · see citing works
Self-citationThe role of gut microbiota in cancer treatment: friend or foe?
Cheng, W. Y., Wu, C.-Y., & Yu, J. (2020) · Gut · doi:10.1136/gutjnl-2020-321153 · Cited by 384 · see citing works
Matson, V., Chervin, C. S., & Gajewski, T. F. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.11.041 · Cited by 385 · see citing works
Lower Airway Dysbiosis Affects Lung Cancer Progression
Tsay, J.-C. J., Wu, B. G., Sulaiman, I., Gershner, K., Schluger, R., Li, Y., Yie, T.-A., Meyn, P., Olsen, E., Perez, L., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0263 · Cited by 322 · see citing works
Tumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323 · see citing works
Specific Gut Microbiome Signature Predicts the Early-Stage Lung Cancer
Zheng, Y., Fang, Z., Xue, Y., Zhang, J., Zhu, J., Gao, R., Yao, S., Ye, Y., Wang, S., Lin, C., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1737487 · Cited by 301 · see citing works
Immunomodulation by targeted anticancer agents
Petroni, G., Buqué, A., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.11.009 · Cited by 212 · see citing works
γδ T cells and adipocyte IL-17RC control fat innervation and thermogenesis
Hu, B., Jin, C., Zeng, X., Resch, J. M., Jedrychowski, M. P., Yang, Z., Desai, B. N., Banks, A. S., Lowell, B. B., Mathis, D., et al. (2020) · Nature · doi:10.1038/s41586-020-2028-z · Cited by 180 · see citing works
Self-citationMicrobiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?
Derosa, L., Routy, B., Desilets, A., Daillère, R., Terrisse, S., Kroemer, G., & Zitvogel, L. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0236 · Cited by 170 · see citing works
Microbiome and Breast Cancer: New Role for an Ancient Population
Eslami-S, Z., Majidzadeh-A, K., Halvaei, S., Babapirali, F., & Esmaeili, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00120 · Cited by 153 · see citing works
Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment
Gao, Z., Bai, Y., Lin, A., Jiang, A., Zhou, C., Cheng, Q., Liu, Z., Chen, X., Zhang, J., & Luo, P. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01722-0 · Cited by 138 · see citing works
Dectin-1 signaling on colonic γδ T cells promotes psychosocial stress responses
Zhu, X., Sakamoto, S., Ishii, C., Smith, M. D., Ito, K., Obayashi, M., Unger, L., Hasegawa, Y., Kurokawa, S., Kishimoto, T., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01447-8 · Cited by 99 · see citing works
Melanoma and microbiota: Current understanding and future directions
Routy, B., Jackson, T., Mählmann, L., Baumgartner, C. K., Blaser, M., Byrd, A., Corvaia, N., Couts, K., Davar, D., Derosa, L., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2023.12.003 · Cited by 89 · see citing works
Peng, D. H., Rodriguez, B. L., Diao, L., Gaudreau, P.-O., Padhye, A., Konen, J. M., Ochieng, J. K., Class, C. A., Fradette, J. J., Gibson, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22875-w · Cited by 72 · see citing works
Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy
Davar, D., & Zarour, H. M. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1129 · Cited by 40 · see citing works
Computational methods and challenges in analyzing intratumoral microbiome data
Wang, Q., Liu, Z., Ma, A., Li, Z., Liu, B., & Ma, Q. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.01.011 · Cited by 37 · see citing works
Galeano Niño, J. L., Wu, H., LaCourse, K. D., Srinivasan, H., Fitzgibbon, M., Minot, S. S., Sather, C., Johnston, C. D., & Bullman, S. (2023) · Nature Protocols · doi:10.1038/s41596-023-00888-7 · Cited by 36 · see citing works
Self-citationGuillot, N., Roméo, B., Manesh, S. S., Milano, G., Brest, P., Zitvogel, L., Hofman, P., & Mograbi, B. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.08.004 · Cited by 36 · see citing works
Sepich‐Poore, G. D., Guccione, C., Laplane, L., Pradeu, T., Curtius, K., & Knight, R. (2022) · BioEssays · doi:10.1002/bies.202100252 · Cited by 33 · see citing works
Said, S., & Ibrahim, W. (2025) · Cancer Management and Research · doi:10.2147/cmar.s405590 · Cited by 25 · see citing works
- Authors
- Jin, C., Lagoudas, G. K., Zhao, C., Bullman, S., Bhutkar, A., Hu, B., Ameh, S., Sandel, D., Liang, X. S., Mazzilli, S., Whary, M. T., Meyerson, M., Germain, R., Blainey, P. C., Fox, J. G., & Jacks, T.
- Affiliations
- Koch Institute for Integrative Cancer Research At MIT (US)
- Massachusetts Institute of Technology (US)
- National Institutes of Health (US)
- Broad Institute (US)
- Dana-Farber Cancer Institute (US)
- Boston University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Jacks, Tyler
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 176
- Issue
- 5
- Pages
- 998-1013.e16
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC6691977
- OpenAlex
- W2912967789
- Cited by
- 964
- References
- 63
- Citations by year
- 2026: 99 · 2025: 153 · 2024: 146 · 2023: 158 · 2022: 145 · 2021: 126 · 2020: 88 · 2019: 47 · 2018: 1
- FWCI
- 42.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-nd)
- PMC
- Funders
- Helen Hay Whitney Foundation-Merck
- Margaret A. Cunningham Immune Mechanisms in Cancer Research (CA226400)
- National Cancer Institute
- Broad’s Next10 Award
- Hugh Hampton (CA229984)
- NCI
- CRI (W81XWH-15-1-0623)
- Department of Defense (CA185020, P30-CA14051)
- Howard Hughes Medical Institute
- Broad Institute
- Burroughs Wellcome Fund (P30-ES002109)
- NHLBI
- NIAID, NIH
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- lung cancer, commensal microbiota, γδ T cells, lung adenocarcinoma, MyD88, IL-1β, IL-23, IL-17, KRAS mutation, p53 deficiency, chronic inflammation, microbiota-immune crosstalk, germ-free mice, antibiotic-treated mice, myeloid cells
- MeSH terms
- Intraepithelial Lymphocytes, Host Microbial Interactions, Animals, Female, Lung, Lung Neoplasms, Male, Mice, Inbred C57BL, Neutrophils, Symbiosis, T-Lymphocytes, Receptors, Antigen, T-Cell, gamma-delta, Interleukin-17, Cell Proliferation, Mice, Interleukin-1beta, Myeloid Differentiation Factor 88, Interleukin-23, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review